Viewing Study NCT02791334


Ignite Creation Date: 2025-12-25 @ 2:39 AM
Ignite Modification Date: 2026-02-25 @ 7:04 PM
Study NCT ID: NCT02791334
Status: COMPLETED
Last Update Posted: 2024-09-27
First Post: 2016-06-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors
Sponsor: Eli Lilly and Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module